Emerging targets and uses of neuromodulation for pain.


Journal

Expert review of neurotherapeutics
ISSN: 1744-8360
Titre abrégé: Expert Rev Neurother
Pays: England
ID NLM: 101129944

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 27 1 2019
medline: 28 7 2020
entrez: 26 1 2019
Statut: ppublish

Résumé

There has been great development in the testing of invasive and non-invasive neuromodulation for chronic pain. To date, it is known that central and peripheral stimulation targets, combined or not, may influence chronic pain sensation. Although most of the significant results of chronic pain studies come from motor cortex stimulation, novel targets are being explored to increase effect sizes and to induce pain relief in non-responders. Areas covered: In this article, we discuss three emerging targets of non-invasive neuromodulation for chronic pain: (i) a central target: prefrontal cortex stimulation; (ii) a peripheral target: vagal nerve stimulation (VNS); and (iii) a combined peripheral-central target: combination of central and peripheral neural stimulation. Expert commentary: Clinical trials' results on novel targets for chronic pain are at an earlier stage and the mechanisms involved with their combination remain unclear. An important challenge to validate new targets is to determine whether they may be equivalent or even more effective than traditional ones. In spite of the significant advance in this field, especially in refractory chronic pain, mechanistic elements are yet to be comprehended. Thus, exploring multifactorial aspects of novel brain stimulation approaches is fundamental to achieve meaningful results and further augment clinical practice.

Identifiants

pubmed: 30681009
doi: 10.1080/14737175.2019.1567332
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-118

Auteurs

Beatriz Costa (B)

a Spaulding Neuromodulation Center, Spaulding Rehabilitation Center and Massachusetts General Hospital , Harvard Medical School , Boston , Massachusetts (MA) , USA.

Isadora Ferreira (I)

a Spaulding Neuromodulation Center, Spaulding Rehabilitation Center and Massachusetts General Hospital , Harvard Medical School , Boston , Massachusetts (MA) , USA.

Alisson Trevizol (A)

a Spaulding Neuromodulation Center, Spaulding Rehabilitation Center and Massachusetts General Hospital , Harvard Medical School , Boston , Massachusetts (MA) , USA.

Aurore Thibaut (A)

a Spaulding Neuromodulation Center, Spaulding Rehabilitation Center and Massachusetts General Hospital , Harvard Medical School , Boston , Massachusetts (MA) , USA.

Felipe Fregni (F)

a Spaulding Neuromodulation Center, Spaulding Rehabilitation Center and Massachusetts General Hospital , Harvard Medical School , Boston , Massachusetts (MA) , USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH